Trademarkia Logo

Canada

C$
EmpowerPharm
SEARCHED

on 10 Dec 2024

Last Applicant/ Owned by

EmpowerPharm Inc.

5575 North Service RoadSuite 603Burlington

ONTARIO

CA

L7L6M1

Serial Number

2102617 filed on 27th Apr 2021

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

EmpowerPharm

Trademark usage description

pharmaceutical preparations containing synthetic cannabidiol (cbd) for the treatment of various diseases, conditions and disorders; pharmaceutical pre Read More

Classification Information


Class [001]
Chemicals and adhesives


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of various diseases, conditions and disorders; Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of anxiety, stress, pain and insomnia; Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of anxiety; Natural health products, namely, glucosamine, turmeric supplements, dietary supplements to aid digestion, melatonin, sleep support supplements, fish oils, probiotics in tablet, capsule, gummy vitamin and liquid form; vitamin supplements; mineral supplements; vitamin and mineral food supplements; vitamin and mineral dietary supplements; vitamin preparations; mineral preparations; multivitamins; prenatal vitamins; calcium supplements; nutritional supplements for general health and well-being, namely magnesium in tablets, capsules, gummies, and liquids; dietary supplements for promoting weight loss; over the counter medications for treating aches, pains, headaches, arthritis pain, sprains, and for treatment of minor joint injuries and muscle soreness, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, namely probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system, antidiarrhea medicines, loperamide, bismuth, nausea treatment preparations, pharmaceutical preparations for the treatment of vomiting and motion sickness, dimenhydrinate; cannabidiol (CBD) oil for medical purposes; cannabidiol (CBD) for medical purposes; cannabidiol (CBD) for medical purposes in the form of suppositories, sublingual doses that dissolve in the mouth, creams, ointments, and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD); herbal supplements containing cannabidiol (CBD); Liquid nutritional supplement containing cannabidiol (CBD) for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia; tetrahydrocannabinol (THC) for medical purposes; tetrahydrocannabinol (THC) for medical purposes in sublingual doses and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquid for therapeutic purposes containing tetrahydrocannabinol (THC) and containing a combination of tetrahydrocannabinol (THC) together with cannabidiol (CBD)


Classification kind code

11

Class [029]
Meats and processed foods


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Development of pharmaceutical preparations; pharmaceutical product evaluation; pharmaceutical research and development; clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials


Classification kind code

11

Mark Details


Serial Number

2102617

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 10th Dec 2024
Search Recorded
Submitted for opposition 20
on 10th Dec 2024
Examiner's First Report
Submitted for opposition 67
on 27th Sept 2024
Agent Name Changed
Submitted for opposition 135
on 16th Dec 2022
Amendment to Application
Submitted for opposition 287
on 4th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 27th Apr 2021
Filed
Submitted for opposition 1
on 27th Apr 2021
Created
Submitted for opposition 31
on 27th Apr 2021
Formalized